Compare $ACXP vs $LIANY | Chartloom

Compare

$ACXP vs $LIANY

Acurx Pharmaceuticals Inc · LianBio

ACXP

Acurx Pharmaceuticals Inc

LIANY

LianBio

Compare $ACXP vs $LIANY

Comparing Acurx Pharmaceuticals Inc and LianBio

ACXPAcurx Pharmaceuticals Inc

LIANYLianBio

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

LIANYLianBio

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-69.8%

FCF yield

-1287.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

LIANY

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

LIANY

LianBio

Market Cap

ACXP$5M

LIANY$7M

Enterprise Value

ACXP$-5M

LIANY$-97M

Price

ACXP$1.27

LIANY$0.06

P/E Ratio

ACXPN/A

LIANYN/A

P/S Ratio

ACXP0.00x

LIANY0.00x

EV/Sales

ACXP0.00x

LIANY0.00x

EV/EBITDA

ACXP0.00x

LIANY0.00x

P/B Ratio

ACXP0.87x

LIANY0.03x

P/FCF Ratio

ACXPN/A

LIANYN/A

EV/FCF

ACXP0.84x

LIANY1.15x

PEG Ratio

ACXPN/A

LIANYN/A

Forward P/E (NTM)

ACXPN/A

LIANYN/A

Forward P/S (NTM)

ACXPN/A

LIANYN/A

Revenue (TTM)

ACXP$0

LIANY$0

Revenue Growth (YoY)

ACXPN/A

LIANYN/A

Forward Rev Growth

ACXP40.7%

LIANY0.0%

Gross Margin (TTM)

ACXP0.0%

LIANY0.0%

Operating Margin (TTM)

ACXP0.0%

LIANY0.0%

EBITDA Margin (TTM)

ACXP0.0%

LIANY0.0%

Net Margin (TTM)

ACXP0.0%

LIANY0.0%

FCF Margin (TTM)

ACXPN/A

LIANYN/A

Net Income (TTM)

ACXP$-8M

LIANY$-88M

FCF (TTM)

ACXP$-6M

LIANY$-84M

EPS (TTM)

ACXP-$1.76

LIANY-$0.82

ROE (TTM)

ACXP-12474.0%

LIANY-3807.0%

ROA (TTM)

ACXP-8749.0%

LIANY-3023.0%

ROIC (TTM)

ACXP-12474.0%

LIANY-3807.0%

Cash

ACXP$11M

LIANY$104M

Debt

ACXP$0

LIANY$0

Net Cash/Debt

ACXP$11M

LIANY$104M

Current Ratio (TTM)

ACXP3.88x

LIANY10.07x

Quick Ratio (TTM)

ACXP3.80x

LIANY9.92x

Debt/Equity (TTM)

ACXP0.00x

LIANY0.00x

Debt/Assets (TTM)

ACXP0.0%

LIANY0.0%

Interest Coverage (TTM)

ACXPN/A

LIANYN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

LIANY0.00x

Beta

ACXP-2.14

LIANY0.16

52W Performance

ACXP-84.3%

LIANY-69.8%

YTD Performance

ACXP-54.0%

LIANY-36.4%

% from 52W High

ACXP-84.4%

LIANY-86.3%

% from 52W Low

ACXP3.3%

LIANY186.3%

Asset Turnover (TTM)

ACXP0.00x

LIANY0.00x

FCF Yield (TTM)

ACXP-113.2%

LIANY-1287.0%

Earnings Yield (TTM)

ACXP-137.5%

LIANY-1348.1%

Dividend Yield (TTM)

ACXPN/A

LIANYN/A

Rule of 40

ACXP0.0

LIANY0.0

EV/GP/RG

ACXPN/A

LIANYN/A

Ticker research

View ACXP research View LIANY research

Metric	ACXP Acurx Pharmaceuticals Inc	LIANY LianBio
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$-97M
Price	$1.27	$0.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.03x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-88M
FCF (TTM)	$-6M	$-84M
EPS (TTM)	-$1.76	-$0.82
ROE (TTM)	-12474.0%	-3807.0%
ROA (TTM)	-8749.0%	-3023.0%
ROIC (TTM)	-12474.0%	-3807.0%
Financial Health
Cash	$11M	$104M
Debt	$0	$0
Net Cash/Debt	$11M	$104M
Current Ratio (TTM)	3.88x	10.07x
Quick Ratio (TTM)	3.80x	9.92x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	0.16
52W Performance	-84.3%	-69.8%
YTD Performance	-54.0%	-36.4%
% from 52W High	-84.4%	-86.3%
% from 52W Low	3.3%	186.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-1287.0%
Earnings Yield (TTM)	-137.5%	-1348.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View LIANY research

Valuation

P/S Ratio

ACXP

0.00x

LIANY

0.00x

EV/FCF

ACXP

0.84x

LIANY

1.15x

Growth & revenue

Forward Revenue Growth

ACXP

40.7%

LIANY

0.0%

Profitability & performance

Gross Margin

ACXP

0.0%

LIANY

0.0%

ROE

LIANY

-3807.0%

ACXP

-12474.0%

FCF Yield %

ACXP

-113.2%

LIANY

-1287.0%

52-Week Performance

LIANY

-69.8%

ACXP

-84.3%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

LIANY

LianBio

Market Cap

ACXP$5M

LIANY$7M

Enterprise Value

ACXP$-5M

LIANY$-97M

Price

ACXP$1.27

LIANY$0.06

P/E Ratio

ACXPN/A

LIANYN/A

P/S Ratio

ACXP0.00x

LIANY0.00x

EV/Sales

ACXP0.00x

LIANY0.00x

EV/EBITDA

ACXP0.00x

LIANY0.00x

P/B Ratio

ACXP0.87x

LIANY0.03x

P/FCF Ratio

ACXPN/A

LIANYN/A

EV/FCF

ACXP0.84x

LIANY1.15x

PEG Ratio

ACXPN/A

LIANYN/A

Forward P/E (NTM)

ACXPN/A

LIANYN/A

Forward P/S (NTM)

ACXPN/A

LIANYN/A

Revenue (TTM)

ACXP$0

LIANY$0

Revenue Growth (YoY)

ACXPN/A

LIANYN/A

Forward Rev Growth

ACXP40.7%

LIANY0.0%

Gross Margin (TTM)

ACXP0.0%

LIANY0.0%

Operating Margin (TTM)

ACXP0.0%

LIANY0.0%

EBITDA Margin (TTM)

ACXP0.0%

LIANY0.0%

Net Margin (TTM)

ACXP0.0%

LIANY0.0%

FCF Margin (TTM)

ACXPN/A

LIANYN/A

Net Income (TTM)

ACXP$-8M

LIANY$-88M

FCF (TTM)

ACXP$-6M

LIANY$-84M

EPS (TTM)

ACXP-$1.76

LIANY-$0.82

ROE (TTM)

ACXP-12474.0%

LIANY-3807.0%

ROA (TTM)

ACXP-8749.0%

LIANY-3023.0%

ROIC (TTM)

ACXP-12474.0%

LIANY-3807.0%

Cash

ACXP$11M

LIANY$104M

Debt

ACXP$0

LIANY$0

Net Cash/Debt

ACXP$11M

LIANY$104M

Current Ratio (TTM)

ACXP3.88x

LIANY10.07x

Quick Ratio (TTM)

ACXP3.80x

LIANY9.92x

Debt/Equity (TTM)

ACXP0.00x

LIANY0.00x

Debt/Assets (TTM)

ACXP0.0%

LIANY0.0%

Interest Coverage (TTM)

ACXPN/A

LIANYN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

LIANY0.00x

Beta

ACXP-2.14

LIANY0.16

52W Performance

ACXP-84.3%

LIANY-69.8%

YTD Performance

ACXP-54.0%

LIANY-36.4%

% from 52W High

ACXP-84.4%

LIANY-86.3%

% from 52W Low

ACXP3.3%

LIANY186.3%

Asset Turnover (TTM)

ACXP0.00x

LIANY0.00x

FCF Yield (TTM)

ACXP-113.2%

LIANY-1287.0%

Earnings Yield (TTM)

ACXP-137.5%

LIANY-1348.1%

Dividend Yield (TTM)

ACXPN/A

LIANYN/A

Rule of 40

ACXP0.0

LIANY0.0

EV/GP/RG

ACXPN/A

LIANYN/A

Ticker research

View ACXP research View LIANY research

Metric	ACXP Acurx Pharmaceuticals Inc	LIANY LianBio
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$-97M
Price	$1.27	$0.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.03x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-88M
FCF (TTM)	$-6M	$-84M
EPS (TTM)	-$1.76	-$0.82
ROE (TTM)	-12474.0%	-3807.0%
ROA (TTM)	-8749.0%	-3023.0%
ROIC (TTM)	-12474.0%	-3807.0%
Financial Health
Cash	$11M	$104M
Debt	$0	$0
Net Cash/Debt	$11M	$104M
Current Ratio (TTM)	3.88x	10.07x
Quick Ratio (TTM)	3.80x	9.92x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	0.16
52W Performance	-84.3%	-69.8%
YTD Performance	-54.0%	-36.4%
% from 52W High	-84.4%	-86.3%
% from 52W Low	3.3%	186.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-1287.0%
Earnings Yield (TTM)	-137.5%	-1348.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View LIANY research